Our editorial comments on the ASCO TAPUR study spearheaded by the amazing Richard Schilsky - Vivek Subbiah, MD
JCO Precision Oncology ASCO
oncodaily.com/36050.html

#ASCO #Cancer #JCOPrecisionOncology #OncoDaily #Oncology #TAPURStudy

'TAPUR is an important vehicle to educate oncologists on how to implement precision medicine in clinical practice. #TAPUR is a pragmatic trial.' - Richard Schilsky ASCO #TAPUR study #PrecisionMedicine

Don't miss the #TAPUR Study Virtual Grand Rounds on May 6. This is your chance to learn about our ongoing #TAPUR Study #ClinicalTrial . Expert speakers include Richard Schilsky, Janet Freeman-Daily & Dr. Jens Rueter. Register ➡️ brnw.ch/21wJhvQ #OncTwitter #PrecisionMedicine

Honored 2 join Richard Schilsky & dr.T. Cannon for the 1st ASCO #TAPUR live virtual Grand Rounds 5/11/23. Thrilled 2 share this pic of a #TAPUR study participant & daughter Sylvester Comprehensive Cancer Center, 4 yrs into the study, after all SOC Rx have failed. Hope U help us spread the word and join us!

Mark your calendars for our upcoming virtual Grand Rounds to explore the use of Precision Medicine through the TAPUR Study - ASCO

oncodaily.com/47714.html

#oncodaily #oncology #cancer #PrecisionMedicine #TAPURStudy #ASCO #ClinicalTrial #MedicalResearch #OncologyCommunity

IBC Research Fdn Richard Schilsky ASCO CTCA, part of City of Hope I am reading about the #TAPURstudy now. Interesting stuff. Do you know anyone currently on a TAPUR trial?

Richard Schilsky ASCO CTCA, part of City of Hope Have so appreciated the opportunity to volunteer as an #advocate on the #TAPURstudy molecular tumor board. Learn things during each case discussion! TY ASCO for the opportunity!